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TARP syndrome (talipes equinovarus, atrial septal defect, Robin sequence, and persistence of
the left superior vena cava) is a rare X-linked syndrome often resulting in pre- or post-natal
lethality in affected males. In 2010, RBM10 was identified as the disease-causing gene, and we
describe the first adult patient with TARP syndrome at age 28 years, hereby expanding the phe-
notypic spectrum. Our patient had Robin sequence, atrial septal defect, intellectual disability,
scoliosis, and other findings previously associated with TARP syndrome. In addition, he had a
prominent nose and nasal bridge, esotropia, displacement of lacrimal points in the cranial direc-
tion, small teeth, and chin dimple, which are the findings that have not previously been associ-
ated with TARP syndrome. Our patient was found to carry a hemizygous c.273_283delinsA
RBM10 mutation in exon 4, an exon skipped in three of five protein-coding transcripts, suggest-
ing a possible explanation for our patient surviving to adulthood. Direct sequencing of maternal
DNA indicated possible mosaicism, which was confirmed by massive parallel sequencing. One of
two sisters were heterozygous for the mutation. Therefore, we recommend sisters of patients
with TARP syndrome be carrier tested before family planning regardless of carrier testing results
of the mother. Based on our patient and previously reported patients, we suggest TARP syn-
drome be considered as a possible diagnosis in males with severe or profound intellectual dis-
ability combined with septal heart defect, and Robin sequence, micrognathia, or cleft palate.
KEYWORDS
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1 | INTRODUCTION
TARP syndrome (OMIM 311900) is a rare X-linked syndrome first
described in 1970 as Robin's syndrome (Gorlin, Cervenka, Anderson,
Sauk, & Bevis, 1970). Talipes equinovarus, atrial septal defect, Robin
sequence, and persistence of the left superior vena cava are the main
features of this syndrome, and thus the syndrome became known as
TARP syndrome in 2003 (Kurpinski, Magyari, Gorlin, Ng, & Biesecker,
2003). In 2010, RBM10 was identified as the causative gene (Johnston
et al., 2010). Seven TARP syndrome families and two patients with a
phenotype overlapping TARP syndrome have previously been
described (Gorlin et al., 1970; Gripp et al., 2011; Johnston et al., 2010;
Johnston et al., 2014; Powis et al., 2017; Wang et al., 2013). In the
first reported families, all patients displayed a phenotype including at
least three of the four findings in the TARP acronym (Supporting
Information Table S1; Gorlin et al., 1970; Johnston et al., 2010; Gripp
et al., 2011). Some later reported patients displayed two or fewer of
these findings (Johnston et al., 2014; Wang et al., 2013). Additional
clinical findings have been reported in patients with hemizygous loss-
of-function mutations in RBM10 (Supporting Information Table S1).
TARP syndrome often results in pre- or post-natal lethality. In 2011,
the oldest patient with TARP syndrome was 3 years and 7 months
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when reported (Gripp et al., 2011), whereas in 2013, two patients
were reported to be 14 years with a phenotype overlapping TARP
syndrome because of a large in-frame deletion in the RBM10 gene
(Wang et al., 2013). Until now, no adult patients with TARP syndrome
have been reported. Here, we report an adult patient with TARP syn-
drome, thus expanding the phenotype in TARP syndrome. We also
present recommendations regarding carrier testing of sisters of
patients with TARP syndrome and suggest a possible cause for the
milder phenotype in our patient.
2 | MATERIALS AND METHODS
2.1 | Clinical report
We report a male patient born in 1989, to non-consanguineous Cauca-
sian parents following a normal pregnancy of 42 gestational weeks. His
birth weight was 2.700 kg (less than second centile for gestational age).
He was diagnosed with Robin sequence shortly after birth and was hos-
pitalized for the first 3 weeks of life because of hypotonia and feeding
and breathing problems. He was diagnosed with severe to profound
intellectual disability in early childhood and had not developed language
at age 28 years. An atrial septal defect was surgically repaired at age
18 years. Surgery for severe thoracolumbar scoliosis was performed at
age 21 years. He was referred for genetic counseling because of family
planning by his two sisters. They sought genetic counseling, when he
was 26 years to evaluate the recurrence risk in the family. Array-CGH
and genetic testing for fragile X syndrome were performed with normal
results. Clinical examination of the patient revealed sloping forehead,
prominent nasal bridge and nose, high myopia, esotropia, displacement
of lacrimal points in the cranial direction, downslanted palpebral fis-
sures, thick eyebrows, prominent supraorbital ridge, unilateral hearing
loss of 75 dB, high and narrow palate, alveolar ridge overgrowth, chin
dimple, and incomplete cutaneous syndactyly of the second and third
toes. The patient did not have talipes equinovarus. In several echocardi-
ographies performed before referral, persistent left superior vena cava
was not described. The patient communicated by sounds of joy or dis-
approval. His gait was broad-based, and he could walk unaided for
short distances. No family members were reported with a similar phe-
notype. A search in medical databases for syndromes to explain our
patient's symptoms resulted in a long list of possible but unlikely diag-
noses including TARP syndrome, which was an unlikely cause because
of the patient's age and scoliosis.
2.2 | Editorial policies and ethical considerations
Informed consent was obtained from our patient, his two sisters, and
his mother.
2.3 | Molecular evaluation
DNA was isolated by standard procedures from blood leukocytes.
Nucleotides were numbered according to the Human Genome Varia-
tion Society guidelines using the NM_005676.4 reference sequence
(den Dunnen et al., 2016). Diagnostic exome sequencing with analysis
of 749 genes associated with intellectual disability (gene panel version
DG-2.5) was performed at Genome Diagnostics Nijmegen (Nijmegen,
The Netherlands) on DNA from our patient.
2.4 | Verification and carrier testing
Mutation genotyping of our patient and his family was performed by
direct sequencing analysis of exon 4 of the RBM10 gene using forward
primer 50-GTCTGGTGTCACTCATCTCATTCTG-30 and reverse primer
50-GCACGTACGTCATCCTCAGT-30. The PCR amplification was per-
formed using OneTaq Hot Start DNA polymerase with GC buffer
(New England Biolabs, Ipswich, MA) according to the manufacturer's
instructions.
For targeted massive parallel sequencing, amplicon libraries
were prepared using the Ion AmpliSeq library kit with target ampli-
fication of the RBM10 gene included in the Ion Ampliseq™ cardio-
vascular research panel (Thermo Fisher Scientific Inc., Waltham,
MA). Template preparation was performed on the Ion Chef and
sequencing on the Ion Proton (Thermo Fisher Scientific Inc.). Man-
ual inspection and visualization of BAM files was achieved using
the Genome Browse function of VarSeq, Version 1.4.4 (Golden
Helix Inc., Bozeman, MT).
3 | RESULTS
The diagnostic exome sequencing revealed the hemizygous
c.273_283delinsA mutation in exon 4 of the RBM10 gene in the
patient, a mutation not previously reported. The subsequent direct
sequencing confirmed the c.273_283delinsA mutation in a hemizy-
gous state in the patient and revealed the same mutation in a hetero-
zygous state in one of the two sisters. The other sister and the
mother were tested negative for the mutation by direct sequencing
analysis (Figure 1). However, the mother's electropherogram sug-
gested possible mosaicism. Maternal mosaicism was confirmed by tar-
geted massive parallel sequencing where 4 of 16 reads were found to
be mutated (Supporting Information Figure S1). The degree of mosai-
cism could not be determined because of low-sequencing depth.
4 | DISCUSSION
We report an adult patient with TARP syndrome. Previously reported
patients with TARP syndrome demonstrate variability of the pheno-
type (Supporting Information Table S1). The first reported families of
TARP syndrome described the syndrome as a pre- or post-natal lethal
condition (Gorlin et al., 1970; Johnston et al., 2010). However, later
reported families (Gripp et al., 2011; Johnston et al., 2014) have
included patients surviving into early childhood. Two patients were
reported at age 14 years, with a phenotype-overlapping TARP syn-
drome and a large in-frame RBM10 deletion (Wang et al., 2013). Our
patient has two of the four findings corresponding to the TARP acro-
nym and other findings previously associated with TARP syndrome
(Supporting Information Table S1; Gorlin et al., 1970; Johnston et al.,
2010; Gripp et al., 2011; Wang et al., 2013; Johnston et al., 2014;
Powis et al., 2017). He also presented with alveolar ridge overgrowth,
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prominent nasal bridge and nose, chin dimple, esotropia, and displace-
ment of lacrimal points in the cranial direction, which are likely part of
the phenotypical spectrum of TARP syndrome in adults.
No loss-of-function mutations in RBM10 are registered in the
Exome Aggregation Consortium (ExAC) database or the Genome
Aggregation Database (gnomAD) (Lek et al., 2016). All previously
reported hemizygous loss-of-function RBM10 mutations have been
associated with TARP syndrome (Gripp et al., 2011; Johnston et al.,
2010, 2014; Powis et al., 2017; Wang et al., 2013). The novel
c.273_283delinsA RBM10 mutation creates a frameshift at codon
91 which produces a premature stop codon 40 positions downstream
(p.(Gly92Alafs*39)). This is likely to shorten RBM10 mRNA that may
undergo nonsense-mediated decay and thus result in no or little protein
production. The c.273_283delinsA mutation, however, is the first
reported loss-of-function mutation in exon 4, which is skipped in three
of five NCBI-curated protein-coding RBM10 transcripts (Figure 2)
(O'Leary et al., 2016). The three transcripts without exon 4 are likely
unaffected by the mutation. Therefore, we suggest alternative splicing
as a possible cause for the milder phenotype in our patient, resulting in
his survival into adulthood. Further studies on the expression of the dif-
ferent RBM10 transcripts in different tissues are needed to investigate
this further.
The RBM10 gene is included in some massive parallel sequenc-
ing gene panels for intellectual disability, congenital heart
FIGURE 1 (a) Pedigree of the family wt, wild-type; m: c.273_283delinsA mutation in the RBM10 gene. (b) Direct sequencing electropherograms
of part of exon 4 in the RBM10 gene in the index patient (II.2), the mother (I.1), and a sister (II.1). The electropherogram of I.1 suggests mosaicism.
(c–e) Photographs of the index patient. Features include wide mouth, sloping forehead, prominent nasal bridge, prominent nose, thick eyebrows,
prominent supraorbital ridge, high and narrow palate, alveolar ridge overgrowth, chin dimple, and micrognathia. Upper front teeth are missing
because of trauma. The black bars covering the eyes are by request of the legal guardian of the patient [Color figure can be viewed at
wileyonlinelibrary.com]
FIGURE 2 Protein-coding transcripts of RBM10 curated by NCBI staff. The c.273_283delinsA mutation (this case report) is the first loss-of-
function mutation identified in exon 4. The four other transcript variants differ from transcript variant 1 (NM_005676.4) in three ways.
The starting codon is in exon 1 in transcript variant 5 (NM_001204468.1). Exon 4 is skipped in transcript variants 2 (NM_152856.2) and
3 (NM_001204466.1). Exon 10 is shortened by three bases in transcript variants 2 and 4 (NM_001204467.1)
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malformations, and malformation syndromes with cleft palate. The
inclusion of the RBM10 gene in the diagnostic gene panel chosen
was essential for reaching the right diagnosis in our patient, as our
initial search in medical databases, based on the patient's clinical
findings, gave a long list of possible diagnoses but did not guide us
to a likely diagnosis. TARP syndrome was initially believed to be an
unlikely diagnosis owing to our patient's age and scoliosis. Inclusion
of RBM10 in additional gene panels may result in identification of
more adult patients with TARP syndrome, possibly expanding the
phenotype further in the near future. Milder mutations, such as mis-
sense mutations, may theoretically cause a milder phenotype. Based
on our patient and previously reported patients, we suggest TARP
syndrome be considered in men with severe or profound intellectual
disability, atrial or ventricular septal defect, and Robin sequence,
micrognathia, or cleft palate.
5 | CONCLUSION
We report the first adult male with TARP syndrome and suggest alter-
native splicing as a possible cause for the milder phenotype in our
patient, resulting in his survival into adulthood. Based on our patient
and previously reported patients, TARP syndrome should be consid-
ered as a possible diagnosis in males with severe or profound intellec-
tual disability combined with atrial or ventricular septal defect and
Robin sequence, micrognathia, or cleft palate. Because of the risk of
low-grade mosaicism in female carriers, preconception carrier testing
should be offered to sisters of patients with TARP syndrome, as a part
of family planning, regardless of whether the mutation has been iden-
tified in the mother despite adequate carrier testing.
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